These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 8342482
1. Sertraline: a new antidepressant. Auster R. Am Fam Physician; 1993 Aug; 48(2):311-4. PubMed ID: 8342482 [Abstract] [Full Text] [Related]
2. Sertraline and breast-feeding. Epperson CN, Anderson GM, McDougle CJ. N Engl J Med; 1997 Apr 17; 336(16):1189-90. PubMed ID: 9102576 [No Abstract] [Full Text] [Related]
3. The role of sertraline in the management of depression. Shelton RC. Clin Ther; 1994 Apr 17; 16(5):768-82; discussion 767. PubMed ID: 7859236 [Abstract] [Full Text] [Related]
4. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Miller HL, Delgado PL, Salomon RM, Berman R, Krystal JH, Heninger GR, Charney DS. Arch Gen Psychiatry; 1996 Feb 17; 53(2):117-28. PubMed ID: 8629887 [Abstract] [Full Text] [Related]
5. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Murdoch D, McTavish D. Drugs; 1992 Oct 17; 44(4):604-24. PubMed ID: 1281075 [Abstract] [Full Text] [Related]
6. [The clinicopharmacological case (5). serotonin reuptake inhibitor and 5-HT3-receptor antagonists: are there clinically relevant interactions?]. Kind B, Fattinger K, Krähenbühl S, Meier-Abt PJ. Praxis (Bern 1994); 1996 Nov 12; 85(46):1490-2. PubMed ID: 8984572 [Abstract] [Full Text] [Related]
8. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions. Finley PR. Ann Pharmacother; 1994 Dec 04; 28(12):1359-69. PubMed ID: 7696728 [Abstract] [Full Text] [Related]
9. Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine. Preskorn SH, Alderman J, Chung M, Harrison W, Messig M, Harris S. J Clin Psychopharmacol; 1994 Apr 04; 14(2):90-8. PubMed ID: 8195463 [Abstract] [Full Text] [Related]
10. Sertraline. A pharmacoeconomic evaluation of its use in depression. Davis R, Wilde MI. Pharmacoeconomics; 1996 Oct 04; 10(4):409-31. PubMed ID: 10184609 [Abstract] [Full Text] [Related]
11. Sertraline treatment of hallucinogen persisting perception disorder. Young CR. J Clin Psychiatry; 1997 Feb 04; 58(2):85. PubMed ID: 9062378 [No Abstract] [Full Text] [Related]
12. [Drug of the month. Sertraline (Serlain)]. Scheen AJ. Rev Med Liege; 1994 Sep 01; 49(9):519-20. PubMed ID: 7939024 [No Abstract] [Full Text] [Related]
14. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Sánchez C, Hyttel J. Cell Mol Neurobiol; 1999 Aug 01; 19(4):467-89. PubMed ID: 10379421 [Abstract] [Full Text] [Related]
15. Clinical overview of serotonin reuptake inhibitors. Rickels K, Schweizer E. J Clin Psychiatry; 1990 Dec 01; 51 Suppl B():9-12. PubMed ID: 2147922 [Abstract] [Full Text] [Related]
16. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors. Grimsley SR, Jann MW. Clin Pharm; 1992 Nov 01; 11(11):930-57. PubMed ID: 1464219 [Abstract] [Full Text] [Related]